scholarly journals The impact of competitive sports on menstrual cycle and menstrual disorders, including premenstrual syndrome, premenstrual dysphoric disorder and hormonal imbalances

2020 ◽  
Vol 91 (9) ◽  
pp. 503-512
Author(s):  
Mariola Czajkowska ◽  
Agnieszka Drosdzol-Cop ◽  
Beata Naworska ◽  
Iwona Galazka ◽  
Celina Gogola ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Premenstrual Syndrome ◽  
Premenstrual Dysphoric Disorder ◽  
Competitive Sports ◽  
Menstrual Disorders ◽  
The Impact

Trends in Research Related to Premenstrual Syndrome and Premenstrual Dysphoric Disorder: a Bibliometric Analysis

2020 ◽  
Author(s):  
Mingzhou Gao ◽  
Hui SUN ◽  
Changlong ZHANG ◽  
Dongmei GAO ◽  
Mingqi QIAO
Keyword(s):  
Systematic Review ◽  
Menstrual Cycle ◽  
Bibliometric Analysis ◽  
Young Women ◽  
Premenstrual Syndrome ◽  
Premenstrual Dysphoric Disorder ◽  
The United States ◽  
Anxiety And Depression ◽  
Publication Number ◽  
Research Hotspots

Abstract Background The global incidence of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) is increasing, with increasing suicide reports. However, the bibliometric analysis of global research on PMS and PMDD is rare. We aimed to evaluate the global scientific output of research on PMS and PMDD and to explore their research hotspots and frontiers from 1945 to 2018 using a bibliometric analysis methodology.Methods Articles with research on PMS and PMDD between 1945 and 2018 were retrieved from the Web of Science Core Collection (WoSCC). We used the bibliometric method, CiteSpace V and VOSviewer to analyze publication years, journals, countries, institutions, authors, research hotspots, and trends. We plotted the reference co-citation network, and we used keywords to analyze the research hot spots and trends.Results We identified 2,833 publications on PMS and PMDD research from 1945 to 2018, and the annual publication number increased with time, with fluctuations. Psychoneuroendocrinology published the highest number of articles. The United States ranked the highest among the countries with the most publications, and the leading institute was UNIV PENN. Keyword and reference analysis indicated that the menstrual cycle, depression and ovarian hormones were the research hotspots, whereas prevalence, systematic review, anxiety and depression and young women were the research frontiers.Conclusions We depicted overall research on PMS and PMDD by a bibliometric analysis methodology. Prevalence and impact in young women , systematic review evaluations of risk factors, and the association of anxiety and depression with menstrual cycle phases are the latest research frontiers that will pioneer the direction of research in the next few years.

scholarly journals Current factors affecting the menstrual cycle

2020 ◽  
Vol 2 (1) ◽  
pp. 18-21
Author(s):  
Godari Akhila ◽  
Asra Shaik ◽  
R. Dinesh Kumar
Keyword(s):  
Menstrual Cycle ◽  
Lifestyle Factors ◽  
Reproductive Age ◽  
Menstrual Disorders ◽  
Important Indicator ◽  
Factors Affecting ◽  
Menstrual Patterns ◽  
The Impact ◽  
Skipping Breakfast

A regular menstrual cycle is an important indicator of a healthy reproductive system. Menstrual problems affect not only women but also families, social & national economy as well. The menstrual cycle is divided into two 14-day phases. In normal healthy women, menarche occurs between the ages 10 and 16 years, with an average rhythm of 28 days, inclusive of 4–6 days of bleeding, with some common minor variations like Amenorrhoea, Oligomenorrhoea, Polymenorrhoea, Menorrhagia, Hypomenorrhoea, etc., these menstrual disorders frequently affect the quality of life of young adults women, some of the lifestyle factors like obesity, intake of junk food, stress, lack of physical activity, skipping breakfast are associated with irregular menstruation. The purpose of this study is to identify menstrual irregularities and assess the impact of lifestyle factors and on the menstrual patterns in reproductive-age females.

Effects Of Exogenous Melatonin On Sleep And Circadian Rhythms In Women With Premenstrual Dysphoric Disorder

SLEEP ◽  
2021 ◽  
Author(s):  
Christophe Moderie ◽  
Philippe Boudreau ◽  
Ari Shechter ◽  
Paul Lesperance ◽  
Diane B Boivin
Keyword(s):  
Menstrual Cycle ◽  
Slow Wave Sleep ◽  
Core Body Temperature ◽  
Premenstrual Dysphoric Disorder ◽  
Ovarian Hormones ◽  
Exogenous Melatonin ◽  
Plasma Melatonin ◽  
Menstrual Symptoms ◽  
The Impact ◽  
Intervention Condition

Abstract We previously found normal polysomnographic (PSG) sleep efficiency, increased slow wave sleep (SWS) and a blunted melatonin secretion in women with premenstrual dysphoric disorder (PMDD) compared to controls. Here, we investigated the effects of exogenous melatonin in five patients previously studied. They took 2 mg of slow-release melatonin 1 hour before bedtime during their luteal phase (LP) for three menstrual cycles. At baseline, patients spent every third night throughout one menstrual cycle sleeping in the laboratory. Measures included morning urinary 6-sulfatoxymelatonin (aMt6), PSG sleep, nocturnal core body temperature (CBT), visual analogue scale for mood (VAS-Mood), Prospective Record of the Impact and Severity of Menstrual Symptoms (PRISM), and ovarian hormones. Participants also underwent two 24-hour intensive physiological monitoring (during the follicular phase and LP) in time-isolation/constant conditions to determine 24-hour plasma melatonin and CBT rhythms. The same measures were repeated during their third menstrual cycle of melatonin administration. In the intervention condition compared to baseline, we found increased urinary aMt6 (p<0.001), reduced objective SOL (p=0.01), reduced SWS (p<0.001) and increased Stage 2 sleep (p<0.001). Increased urinary aMt6 was associated with reduced SWS (r=-0.51, p<0.001). Circadian parameters derived from 24-hour plasma melatonin and CBT did not differ between conditions, except for an increased melatonin mesor in the intervention condition (p=0.01). Ovarian hormones were comparable between the conditions (p≥0.28). Symptoms improved in the intervention condition, as measured by the VAS-Mood (p=0.02) and the PRISM (p<0.001). These findings support a role for disturbed melatonergic system in PMDD that can be partially corrected by exogenous melatonin.

scholarly journals Premenstrual syndrome and cortisol

2021 ◽  
Vol 16 (1) ◽  
pp. 11-14
Author(s):  
Florica SANDRU ◽  
◽  
Mihai Cristian DUMITRASCU ◽  
Eugenia PETROVA ◽  
Adina GHEMIGIAN ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Premenstrual Syndrome ◽  
Gaba Receptors ◽  
Statistical Power ◽  
Pain Perception ◽  
Premenstrual Dysphoric Disorder ◽  
Cycle Phase ◽  
Area Of Interest ◽  
Response To Stress ◽  
Suppression Test

Premenstrual syndrome (PMS), including the severe subtype premenstrual dysphoric disorder (PMDD), DSM-5 category, represents a challenging combination of hormonal, environmental and neuroendocrine dysfunctions with menstrual cycle-related pattern. Controversies around the role of daily stress and associated anomalies of hypothalamic-pituitary-adrenal axis are related to the fact that stress is all the time, not just a fluctuating element. This is a narrative review on PMS/PMDD and cortisol profile. 46 articles are cited (between 2009 and 2020). PMD/PMDD underlines multiple imbalances and anomalies of the cortisol levels or its secretory pattern may be a few of them, despite the fact that multiple controversies are still present and most of studies are of limited statistical power. Women with PMS may have higher levels of cortisol in relationship to stress independently of the cycle phase, also a delay of CAR (cortisol awakening response) peak and a delayed cortisol slope during day time. It does not seem that CAR pattern is related to the phases of menstrual cycle. CAR anomalies may be associated with pain perception disturbances in PMS females. The most modern area of interest is related to allopregnanolone, a progesterone metabolite with neuroactive profile. The diurnal serum baseline cortisol and the values of cortisol after dexamethasone suppression test may be similar between patients with PMS and without, but the females with PMS that have higher allopregnanolone associate blunted values of cortisol during the night versus control (without PMS) and versus women with low allopregnanolone levels, thus proving a suboptimal response to stress. Allopregnanolone modules GABA receptors on a paradoxical manner inducing anxiety and irritability during luteal phase on women with a specific predisposal configuration of GABA receptor as those confirmed with PMDD. Overall, PMS/PMDD impairs the quality of life, thus the more we understand about its pathogeny, the easier it gets to control it.

An Overview of Premenstrual Voice Syndrome: Definition, Treatment, and Future Trajectories

2020 ◽  
Vol 35 (1) ◽  
pp. 59-65
Author(s):  
Sasha L Kaye
Keyword(s):  
Menstrual Cycle ◽  
Premenstrual Syndrome ◽  
Symptom Management ◽  
Premenstrual Dysphoric Disorder ◽  
Sound Quality ◽  
Career Longevity ◽  
Voice Production ◽  
Tone Quality ◽  
Classical Singers ◽  
The Voice

For classical singers, performing in peak condition is optimal at all times in an industry which demands excellence. The slightest variability in a singer’s physiology can influence sound quality and production; in severe instances, a singer’s career longevity may be compromised. Researchers have observed an effect of menstrual cycle hormone variability on the voice, compromising tone quality, agility, and stamina. For a subset of these singers, the effect of hormone variability on voice production is especially severe. This phenomenon has been termed premenstrual voice syndrome (PMVS) among singers, although there has been little empirical research on PMVS, which complicates matters related to defining, taxonomizing, and treating the condition. This article offers an overview of existing research related to PMVS, identifies gaps in definitional and categorical boundaries between PMVS and premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), and offers recommendations for symptom management as well as suggestions for pedagogues and teachers to better educate themselves and their students about PMVS.

scholarly journals Menstrual Cycle in Female Workers

2020 ◽  
Vol 1 (1) ◽  
pp. 29-34
Author(s):  
Thu Huong Nguyen
Keyword(s):  
Physical Activity ◽  
Menstrual Cycle ◽  
Premenstrual Dysphoric Disorder ◽  
Uterine Wall ◽  
Menstrual Blood ◽  
Menstrual Disorders ◽  
Abnormal Growth ◽  
Female Workers ◽  
Physiological Disorders ◽  
Menstrual Irregularities

Menstrual disorders are abnormalities that occur in the menstrual cycle. There are various menstrual disorders that women can experience, ranging from too little or too much menstrual blood, painful menstruation, to depression before menstruation or premenstrual dysphoric disorder. Physical activity is divided into three levels, namely light, moderate and heavy physical activity. Physical activity of heavy intensity can cause physiological disorders of the menstrual cycle. presence of menstruation (amenorrhoea), thinning of the bones (osteoporosis), menstrual irregularities or intermenstrual bleeding, abnormal growth of the uterine wall, and infertility.

738 Effects of exogenous melatonin on sleep, circadian rhythms, and mood in women with premenstrual dysphoric disorder

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A288-A288
Author(s):  
Christophe Moderie ◽  
Ari Shechter ◽  
Paul Lespérance ◽  
Diane Boivin
Keyword(s):  
Menstrual Cycle ◽  
Sleep Disturbances ◽  
Slow Wave Sleep ◽  
Premenstrual Dysphoric Disorder ◽  
Ovarian Hormones ◽  
Exogenous Melatonin ◽  
Plasma Melatonin ◽  
Menstrual Symptoms ◽  
The Impact ◽  
Intervention Condition

Abstract Introduction Most women with premenstrual dysphoric disorder (PMDD) report sleep disturbances. Our group found normal polysomnographic (PSG) sleep efficiency and increased slow wave sleep (SWS) across the menstrual cycle in women with PMDD and insomnia compared to controls. Reduced melatonin levels were found in PMDD women compared to controls, with reduced secretion during their luteal phase (LP) compared to follicular phase (FP). Here, we investigated the effects of exogenous melatonin in the patients we previously studied. Methods Five patients (age, mean: 33.6, SD: 2.7) diagnosed prospectively with PMDD and insomnia participated in the study. Following a baseline assessment, patients took 2 mg of slow-release melatonin 1h before bedtime during their LP for three consecutive menstrual cycles. At baseline (treatment-free condition), patients spent every third night of their menstrual cycle sleeping in the laboratory. Measures included morning urinary 6-sulfatoxymelatonin (aMt6), PSG sleep, nocturnal core body temperature (CBT), visual analogue scale for mood (VAS-Mood), Prospective Record of the Impact and Severity of Menstrual symptoms (PRISM), subjective sleep and ovarian hormones (estrogen and progesterone). Participants also underwent two 24-hour intensive physiological monitoring (during the FP and LP) in time-isolation/constant conditions to determine 24-hour plasma melatonin and CBT rhythms. The same measures were repeated during their third menstrual cycle of melatonin administration. Results In the intervention condition compared to baseline, we found increased urinary aMt6 (p<0.001), reduced objective SOL (p=0.01), SWS (p<0.001) and increased Stage 2 sleep (p<0.001). Increased urinary aMt6 was associated with reduced SWS (r=-0.51, p<0.001). Circadian parameters derived from 24-hour plasma melatonin and CBT did not differ between conditions, except for an increased melatonin mesor in the intervention condition (p=0.01). Ovarian hormones were comparable between the conditions (p≥0.28). Symptoms improved in the intervention condition, as measured by the VAS-Mood (p=0.02) and the PRISM (p<0.001). Conclusion We have shown normalization of SWS and reduction in self-reported mood and somatic symptoms after administrating exogenous melatonin in women with PMDD. These findings support a role for disturbed melatoninergic system in PMDD that can be partially corrected by exogenous melatonin. Support (if any) This study was supported by the Canadian Institutes of Health Research (CIHR)

Premenstrual syndrome

2013 ◽  
Vol 6 (5) ◽  
pp. 302-306
Author(s):  
Shiva Shanmugaratnam ◽  
Hari Shanmugaratnam ◽  
Miss Maryam Parisaei
Keyword(s):  
Quality Of Life ◽  
General Practice ◽  
Menstrual Cycle ◽  
Premenstrual Syndrome ◽  
Luteal Phase ◽  
Psychological Symptoms ◽  
Premenstrual Dysphoric Disorder ◽  
Current Evidence ◽  
Behavioural And Psychological Symptoms

Premenstrual syndrome (PMS) is characterised by cyclical physical, behavioural and psychological symptoms occurring during the luteal phase of the menstrual cycle (the time between ovulation and the onset of menstruation). The symptoms disappear or significantly regress by the end of menstruation. Premenstrual dysphoric disorder (PMDD) is a more severe variant of premenstrual syndrome. PMS is common and severe symptoms can have detrimental effects on a woman's quality of life. GPs play a key role in the diagnosis and management of these conditions. This article aims to provide an overview of the current evidence and guidelines for recognising and managing PMS in general practice.

scholarly journals Trends in Research Related to Premenstrual Syndrome and Premenstrual Dysphoric Disorder From 1945 to 2018: A Bibliometric Analysis

2021 ◽  
Vol 9 ◽  
Author(s):  
Mingzhou Gao ◽  
Dongmei Gao ◽  
Hui Sun ◽  
Xunshu Cheng ◽  
Li An ◽  
...  
Keyword(s):  
Systematic Review ◽  
Menstrual Cycle ◽  
Bibliometric Analysis ◽  
Young Women ◽  
Premenstrual Syndrome ◽  
Premenstrual Dysphoric Disorder ◽  
Anxiety And Depression ◽  
Analysis Methodology ◽  
Research Frontiers ◽  
Research Hotspots

Background: The global incidence of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) is increasing, with increasing suicide reports. However, the bibliometric analysis of global research on PMS and PMDD is rare. We aimed to evaluate the global scientific output of research on PMS and PMDD and to explore their research hotspots and frontiers from 1945 to 2018 using a bibliometric analysis methodology.Methods: Articles with research on PMS and PMDD between 1945 and 2018 were retrieved from the Web of Science Core Collection (WoSCC). We used the bibliometric method, CiteSpace V and VOSviewer to analyze publication years, journals, countries, institutions, authors, research hotspots, and trends. We plotted the reference co-citation network, and we used keywords to analyze the research hotspots and trends.Results: We identified 2,833 publications on PMS and PMDD research from 1945 to 2018, and the annual publication number increased with time, with fluctuations. Psychoneuroendocrinology published the highest number of articles. The USA ranked the highest among the countries with the most publications, and the leading institute was UNIV PENN. Keyword and reference analysis indicated that the menstrual cycle, depression and ovarian hormones were the research hotspots, whereas prevalence, systematic review, anxiety and depression and young women were the research frontiers.Conclusions: We depicted overall research on PMS and PMDD by a bibliometric analysis methodology. Prevalence and impact in young women, systematic review evaluations of risk factors, and the association of anxiety and depression with menstrual cycle phases are the latest research frontiers that will pioneer the direction of research in the next few years.

Is a Little (Psychiatric) Knowledge a Dangerous Thing?: The Impact of Premenstrual Dysphoric Disorder on Perceptions of Premenstrual Women

1997 ◽  
Vol 21 (2) ◽  
pp. 315-322 ◽  
Author(s):  
Heather C. Nash ◽  
Joan C. Chrisler
Keyword(s):  
Menstrual Cycle ◽  
American Psychiatric Association ◽  
Premenstrual Dysphoric Disorder ◽  
Chi Square ◽  
Statistical Manual ◽  
Diagnostic And Statistical Manual ◽  
Women’S Perceptions ◽  
Dsm Iv ◽  
Menstrual Distress ◽  
The Impact

One hundred thirty-four participants completed a revised Menstrual Distress Questionnaire (MDQ), which included criteria for premenstrual dysphoric disorder (PMDD). Two weeks later the participants again completed the revised MDQ after reading either the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association, 1994) diagnostic criteria for the PMDD or a copy of the same criteria retitled “Episodic Dysphoric Disorder,” with all menstrual cycle references removed. Knowledge of the diagnosis did not affect women's perceptions of their own menstrual cycle-related symptoms, but it increased participants' perceptions of premenstrual changes as a problem for women in general. Chi-square analyses revealed that participants were more willing to attach a psychiatric diagnosis to women they know if they believed the diagnosis was related to the menstrual cycle.

Sign in / Sign up

Export Citation Format

Share Document